3 distinct clinical features: presence of finger nodes (2 or more IPJs); thumb base involvement (1 or more CMCJ); and bony enlargement (2 or more IPJs or MCPJs). The resulting subgroups were then examined using ANOVA for differences in changes in self-reported pain and disability (AUSCAN) at 18 months. Results: 513 participants were eligible for the analysis. Presence of thumb base involvement and then finger nodes were the two most important clinical features in distinguishing subgroups. The overall mean change (SD) in AUSCAN scores in the total sample (baseline-18 months) was −0.27 (4.1) for pain and −0.43 (6.15) for disability (a negative score indicating deterioration). There was deterioration in both pain and disability scores in those participants with thumb involvement (with or without finger nodes) and this was statistically significant after adjusting for baseline AUSCAN score, age and gender (p = 0.02 for pain; p = 0.04 for function). There was a minimal improvement in the participants with finger nodes alone at baseline (Table 1) . Differences did not reach statistical significance. Conclusions: Clinically different sub-groups can be identified in a community dwelling population of older adults with hand problems. Presence of thumb base involvement at baseline contributed to poorer clinical outcome scores at 18 months. These findings are in line with EULAR recommendations for the diagnosis of hand OA. The extent to which clinical subgroups may predict poor long-term outcome in older adults with features of hand OA needs further evaluation. Table 1 Mean AUSCAN change at 18 months ANOVA for Thumb base not involved Thumb base involved group differences No finger nodes (n = 128) Has finger nodes (n = 176) No finger nodes (n = 56) Has finger nodes (n = 153) Pain −0.25 (3.8) 0.27 (4.4) −1.20 (4.2) −0.66 (4.0) P = 0.01; P = 0.11* Disability −0.61 (5.0) 0.36 (6.35) −0.96 (6.39) −0.96 (6.27) P = 0.02; P = 0.14* *Adjusting ANOVA models for baseline AUSCAN score, age and gender.
3 distinct clinical features: presence of finger nodes (2 or more IPJs); thumb base involvement (1 or more CMCJ); and bony enlargement (2 or more IPJs or MCPJs). The resulting subgroups were then examined using ANOVA for differences in changes in self-reported pain and disability (AUSCAN) at 18 months. Results: 513 participants were eligible for the analysis. Presence of thumb base involvement and then finger nodes were the two most important clinical features in distinguishing subgroups. The overall mean change (SD) in AUSCAN scores in the total sample (baseline-18 months) was −0.27 (4.1) for pain and −0.43 (6.15) for disability (a negative score indicating deterioration). There was deterioration in both pain and disability scores in those participants with thumb involvement (with or without finger nodes) and this was statistically significant after adjusting for baseline AUSCAN score, age and gender (p = 0.02 for pain; p = 0.04 for function). There was a minimal improvement in the participants with finger nodes alone at baseline (Table 1) . Differences did not reach statistical significance. Conclusions: Clinically different sub-groups can be identified in a community dwelling population of older adults with hand problems. Presence of thumb base involvement at baseline contributed to poorer clinical outcome scores at 18 months. These findings are in line with EULAR recommendations for the diagnosis of hand OA. The extent to which clinical subgroups may predict poor long-term outcome in older adults with features of hand OA needs further evaluation. Purpose: A new CT-based methodology was recently developed to objectively quantify fracture severity, working from the principle that mechanical energy is necessarily expended to create new free surface area in a brittle solid. The amount of energy thus expended is proportional to the amount of de novo interfragmentary surface area ( Figure 1 ). We now measure other clinically relevant aspects of the comminuted fractures, including fragment displacement and articular fragmentation. To assess these additional measures, we compared them with experienced clinician opinion. In addition, for the first time we report on the ability of the metrics to predict post-traumatic osteoarthritis (PTOA) in ankles of patients with tibial plafond fractures at two years post-injury. We hypothesized that an injury severity metric that included objective measures of articular disruption, of fracture energy, and of fragment displacement/dispersal would be an accurate predictor of PTOA. Methods: Twenty tibial plafond fractures were chosen for study. These cases had previously undergone rank order analysis of overall injury severity by three experienced orthopaedic traumatologists. We now asked the clinicians to rank order these fractures looking at specific components of injury, including fracture displacement and articular comminution. A fragment segmentation algorithm was separately used to objectively measure articular comminution, fragment displacement, and lumped measures of overall fracture severity. Concordance rates were calculated to measure agreement between assessments made by the clinicians, and the CT-based computational measures. Kellgren-Lawrence (KL) scores were assessed at 2 years post-injury. Linear regression models were used to evaluate the ability of various combinations of the fracture severity measures to predict PTOA. Results: Concordance rates between clinican rank ordering and fragment displacement were high with rates from 82 to 89%. At two years postinjury, 13% of the patients had developed minimal PTOA (KL score = 2), and 31% had developed moderate to severe PTOA (KL scores 3). Linear regression indicated that fracture energy and articular comminution, when combined, explain 73% of the variation in PTOA severity; however fragment displacement/dispersal did not correlate as strongly with degeneration (R 2 = 0.42). The combined fracture energy and articular comminution metric was a better predictor of KL scores than was clinician opinion (R 2 of 0.73 vs. 0.47, respectively).
Conclusions:
The findings of this study indicate that an objective CTbased fracture severity metric reasonably predicts subsequent PTOA, providing a strong impetus for further developing this novel paradigm. Financial support was provided by grants from the National Institutes of Health (AR46601, AR55533, and AR48939), The AO Research Fund and The Orthopaedic Trauma Association. Purpose: Subchondral bone attrition (SBA) has become an increasingly important topic of investigation in research on pain and progression in knee osteoarthritis (OA), and is generally thought of as a late, irreversible finding in radiographic OA. SBA probably involves remodelling of the bone, resulting in flattening or depression of the articular surface. However, we lack data on the natural course of radiographic SBA. Methods: Knee radiographs of participants in a population based, longitudinal observational study from the Somerset and Avon Survey of Health (SASH) were assessed for SBA both at baseline and 8 year followup. SBA was graded on posterioranterior weight bearing radiographs on a scale from 0−3 as follows: 0 = no SBA, 1 = mild SBA (<5 mm), 2 = moderate SBA (5−10 mm) and 3 = severe OA (>10 mm). One trained reader (SR) assessed both baseline and follow-up radiographs. We determined SBA to be present in any case with SBA > 0. Progression was considered to have occurred if the SBA grade had increased 8 years later. In addition, we recorded whether a total knee replacement (TKR) had been conducted. Each pair of radiographs was also qualitatively assessed by two independent readers (PD, IW) as follows: no change, progression of joint damage and bone loss, or bone remodeling with no further progression of joint damage. Baseline characteristics of subjects (day pain, night pain) and radiographic characteristics (K/L score, femoral and tibial attrition) were compared between the 4 groups (no change, reformation, progression, TKR).
Results:
We found 48 paired radiographs in 38 study participants where SBA had been read at baseline. Four paired radiographs were excluded in the quality assessment: one radiograph was judged not to have SBA (false positive reading), and three radiographs were judged not to have primary OA (secondary OA due to fractures and inherited malformation). In 19.2%, SBA was found in the femur only, in 37.5% it was only tibial, and in the remaining 33.3% it was found in both locations. K/L grade was high at baseline, indicating severe OA (median = 4, interquartile range (IQR) 3 to 4). At follow up after 8 years, more than half of the knees (54.2%) had been replaced (TKR). 22 paired radiographs without TKR were left for the qualitative assessment of the study: 12 knees were considered to be unchanged (54.5%), 6 knees (27.3%) showed progression, and 4 knees (18.2%) showed bone remodeling or improvement. Radiographs which did not change had a less severe K/L score. Radiographs showing bone remodeling did not differ from those showing progression or no change, but the numbers were small (Table 1) .
Conclusions:
If SBA was seen at baseline, over an 8 year period, 67% showed progression or had a TKR. In those knees not undergoing a TKR, we saw a considerable amount of radiographic bone remodelling or no radiographic change. Progression of pathology is not inevitable in knee OA, even if SBA is present. Purpose: To identify changes in imaging outcomes in a controlled model of osteoarthritis versus exercise in order to differentiate adaptive and pathologic processes using clinical techniques. Methods: 16 2-year-old horses were randomly assigned to an exercise control (n = 8) or an exercise osteoarthritis (n = 8) group. All horses had middle carpal joints arthroscopically explored and an osteochhondral fragment was induced in one middle carpal joint of the osteoarthritis group. All horses were treadmill exercised for the duration of the study (91 days). Clinical, radiographic, nuclear scintigraphic, computed tomographic and MRI examinations were performed and outcomes of these analyses were compared between groups. Imaging results were correlated to clinical, biomarker and gross pathologic results. Data were compared between 3 groups of joints: EXC = both joints from exercise control horses; OAC = sham operated joint from the exercise osteoarthritis group; and OAF = osteoarthritis affected joint from the exercise osteoarthritis group. A Mixed model ANOVA was used to analyze outcomes, and Pearson Correlation Coefficient used to evaluate relationships between dependent variables. Figure 1 .
Results:
The osteoarthritis group had significant increases in clinical outcomes and most imaging parameters. Specifically, the osteoarthritis group showed significant increase in lameness, synovial effusion and response to flexion (Figure 1 ). Radiographic lysis and nuclear scintigraphic uptake were also significantly higher in the osteoarthritis group. There was very little change in subchondral bone density, but a significant change in subchondral bone edema, which was higher in the osteoarthritis group. Radiographic lysis, radial carpal bone edema and nuclear scintigraphic uptake were strongly correlated with clinical changes and radial carpal bone edema was strongly correlated with changes in type I and type II collagen found in the synovial fluid. Conclusions: Osteoarthritis induced significant changes in imaging parameters beyond the adaptation seen with exercise. Bone edema detected with MRI was closely correlated with collagen biomarkers detected in the synovial fluid. Methods: A total of 419 randomly selected subjects (mean 62 years, range 51−80, and 50% female) were studied. T1-weighted fat-suppressed MRI on right knee was performed, and knee cartilage volume at medial and lateral tibial sites and knee cartilage defects (0−4 scale) were measured at baseline and 2.9 years later. Regular medication uses including conventional NSAIDs and selective cyclooxygenase-2 (COX-2) inhibitors in the last month were recorded by questionnaire. Multivariable linear or logistic regression methods were used for statistical analyses. Results: Compared with non users of NSAIDs (n = 346), users of COX-2 inhibitors (n = 49) had decreased knee cartilage defect development in the medial tibiofemoral compartment (OR 0.39, 95% CI 0.15, 0.99) but no greater loss of cartilage volume (b = −0.03% per annum, pa and +0.88% pa at medial and lateral tibial sites, P > 0.05), whereas users of nonselective NSAIDs (n = 24) were associated with increased knee cartilage defect development in both medial (OR: 3.07, 95% CI: 1.04, 9.09) and lateral (OR: 2.61, 95% CI: 1.01, 6.77) tibiofemoral compartments, but again no greater loss of cartilage volume (b = −1.09% pa and −1.10% pa at medial and lateral tibial sites, P > 0.05). Comparing users of COX-2 inhibitors with users of non-selective NSAIDs, the latter had higher knee cartilage volume loss (b = −4.85% pa, 95% CI: −9.00, −0.70 at medial tibia; and b = −4.61%, 95% CI: −8.11, −1.12 at lateral tibia). All models were fully adjusted for potential confounders including knee pain, sex, age, BMI, smoking, steps each day, sun exposure, tibial bone area, radiographic OA, and rheumatoid arthritis.
Conclusions:
This study suggests that non-selective NSAIDs may have deleterious effects while selective COX-2 inhibitors may have beneficial effects on knee joint structure. Randomized controlled trials using MRI techniques to confirm the finding are warranted.
